Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.
Alpha-Fetoprotein, or AFP – normally expressed during development and by liver cancer cells as well – has escaped attack in previous vaccine iterations because the body recognizes it as “self,” said Dr. Yukai He, immunologist at the Medical College of Georgia and Georgia Regents University Cancer Center.
Liver cancer is among the fastest-growing and deadliest cancers in the United States with a 17 percent three-year survival rate. Vaccines help direct the immune system to attack invaders by showing it a representative substance, called an antigen, that the body will recognize as foreign, in this case, AFP for liver cancer.
Read more . . .
The Latest on: Liver cancer
[google_news title=”” keyword=”Liver cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Liver cancer
- Celebrity trainer Gunnar Peterson reveals his 4-year-old has cancer after 'typical kid' symptomson March 27, 2024 at 9:42 pm
Celebrity trainer Gunnar Peterson shared that his his daughter has cancer. In an Instagram post with the news, he shared what symptoms she showed before she was diagnosed.
- Care Plan Your Doctor Would Usually Recommend For Gallbladder Canceron March 27, 2024 at 2:28 pm
Overview Tumor that develops in the gallbladder, a small organ below the liver. It causes jaundice, abdominal pain, bloatinng, weightloss, nausea and vomiting. Symptoms It is characterized by ...
- Pittsburgh initiative World Tumor Registry aims to make cancer diagnosis, research more completeon March 27, 2024 at 2:00 pm
The World Tumor Registry launched this month at a global pathology conference in Baltimore — with a life-changing mission.
- Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needson March 25, 2024 at 5:52 pm
Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety ...
- Midland College student overcomes stage 4 liver cancer, takes one day at a timeon March 24, 2024 at 11:39 am
Midland College student Marcus Avila is overcoming Stage 4 liver cancer, continuing his studies and learning to live one day at a time.
- Helio Genomics Mulls New AI-Driven Dx Opportunities While Readying Liver Cancer Test for USon March 22, 2024 at 12:48 pm
The company recently published data on the MESA platform's ability to screen for colorectal cancer and is considering other testing opportunities.
- After Opdivo flop in liver cancer, Bristol Myers finds Yervoy combo could save liveson March 20, 2024 at 7:18 am
Bristol Myers Squibb is gunning for newly diagnosed unresectable liver cancer—again—after an immunotherapy setback five years ago. | Bristol Myers Squibb is gunning for newly diagnosed unresectable ...
- Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trialon March 20, 2024 at 4:35 am
Bristol Myers Squibb said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating it as an initial treatment for a type of liver cancer.
- Immune evasion tactics of liver cancer cells revealedon March 19, 2024 at 10:13 am
A faulty cancer gene helps tumors evade immunity by stopping tumor cells releasing message-containing cargoes called exosomes. These findings, published in eLife, provide what the editors say is ...
- A pioneering way to target the culprit behind a deadly liver canceron March 14, 2024 at 3:03 pm
Researchers have translated a cutting-edge tactic for treating genetic disorders into a fresh approach for potentially stymying cancer.
via Bing News